These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 8624769
1. Prevalence of and risk factors for HTLV-I and HTLV-II infection among patients at a hospital in the South Bronx, New York. Factor SH, Irwin KL, Lal RB, Rudolph D, Weber TJ, Olivo N, Ernst J. J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May 01; 12(1):97-7. PubMed ID: 8624769 [No Abstract] [Full Text] [Related]
2. HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group. Soriano V, Calderón E, Esparza B, Cilla G, Aguilera A, Gutiérrez M, Tor J, Pujol E, Merino F, Pérez-Trallero E. Int J Epidemiol; 1993 Aug 01; 22(4):716-9. PubMed ID: 8225748 [Abstract] [Full Text] [Related]
3. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City. Brown LS, Chu A, Allain JP, Lee H, Cerney M, Nemoto T. N Y State J Med; 1991 Mar 01; 91(3):93-7. PubMed ID: 2047026 [Abstract] [Full Text] [Related]
4. [Prevalence of HTLV-I and HTLV-II infection in Puglia]. Quarto M, Chironna M, Germinario C, Lopalco PL, Barbuti S. Ann Ig; 1996 Mar 01; 8(6):649-55. PubMed ID: 9312232 [No Abstract] [Full Text] [Related]
5. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. The HTLV European Research Network. J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep 01; 13(1):68-77. PubMed ID: 8797688 [Abstract] [Full Text] [Related]
6. Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Seville, Spain. Calderón EJ, Gómez-Lucia E, Aguado I, Pineda JA, Essex M, Leal M. Eur J Clin Microbiol Infect Dis; 1991 Sep 01; 10(9):773-5. PubMed ID: 1810736 [Abstract] [Full Text] [Related]
12. Low HTLV-I/II seroprevalence in pregnant women in Congo and a geographic cluster of an HTLV-like indeterminate western blot pattern. Tuppin P, Makuwa M, Guerma T, Bazabana MM, Loukaka JC, Jeannel D, M'Pelé P, de Thé G. J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan 01; 11(1):105-7. PubMed ID: 8528728 [No Abstract] [Full Text] [Related]
13. High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen IS. Science; 1989 Apr 28; 244(4903):471-5. PubMed ID: 2655084 [Abstract] [Full Text] [Related]
14. Prevalence of and risk factors for HTLV-I and HTLV-II infection among patients at a hospital in the south Bronx, New York. Factor SH, Irwin KL, Lal RB, Rudolph D, Weber JT, Olivo N, Ernst J. J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug 01; 12(4):431-2. PubMed ID: 8673556 [No Abstract] [Full Text] [Related]
15. Seroprevalence of HTLV-I/II and HIV-1 infection among male intravenous drug abusers in Chicago. Lentino JR, Pachucki CT, Schaaff DM, Schaefer MR, Holzer TJ, Heynen C, Dawson G, Dorus W. J Acquir Immune Defic Syndr (1988); 1991 Aug 01; 4(9):901-9. PubMed ID: 1895212 [Abstract] [Full Text] [Related]
16. Prevalence of HTLV types I and II among drug users in King County, Washington. Thiede H, Harris NV, McGough JP, Roberts B, Khabbaz RF, Kaplan JE. West J Med; 1994 Jun 01; 160(6):540-4. PubMed ID: 8053176 [Abstract] [Full Text] [Related]
19. Prevalence of antibodies to HTLV-I/II in blood donors and risk populations in South China. Cao F, Ji Y, Huang R, Lin S. Vox Sang; 1998 Jun 01; 75(2):154. PubMed ID: 9784671 [No Abstract] [Full Text] [Related]
20. Worldwide distribution of HTLV. Tajima K. Jpn J Cancer Res; 1998 Jan 01; 89(1):inside front cover. PubMed ID: 9510466 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]